Sterling Investment Advisors (Pennsylvania)’s Teva Pharmaceuticals TEVA Stock Holding History

Sterling Investment Advisors (Pennsylvania)’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,000	Closed	-$8K	–	475
2022 Q2	$8K	Hold	1,000	–	–	﹤0.01%	426
2022 Q1	$9K	Hold	1,000	–	–	﹤0.01%	450
2021 Q4	$8K	Hold	1,000	–	–	﹤0.01%	460
2021 Q3	$10K	Hold	1,000	–	–	﹤0.01%	438
2021 Q2	$10K	Hold	1,000	–	–	﹤0.01%	426
2021 Q1	$12K	Hold	1,000	–	–	﹤0.01%	393
2020 Q4	$10K	Hold	1,000	–	–	﹤0.01%	372
2020 Q3	$9K	Hold	1,000	–	–	﹤0.01%	354
2020 Q2	$12K	Hold	1,000	–	–	0.01%	332
2020 Q1	$8K	Hold	1,000	–	–	﹤0.01%	330
2019 Q4	$9K	Hold	1,000	–	–	﹤0.01%	345
2019 Q3	$7K	Hold	1,000	–	–	﹤0.01%	363
2019 Q2	$9K	Hold	1,000	–	–	﹤0.01%	356
2019 Q1	$16K	Hold	1,000	–	–	0.01%	312
2018 Q4	$15K	Hold	1,000	–	–	0.01%	304
2018 Q3	$22K	Hold	1,000	–	–	0.01%	300
2018 Q2	$24K	Hold	1,000	–	–	0.01%	278
2018 Q1	$17K	Hold	1,000	–	–	0.01%	286
2017 Q4	$19K	Hold	1,000	–	–	0.01%	263
2017 Q3	$18K	Sell	1,000 -2,900	-74%	-$65.3K	0.01%	262
2017 Q2	$130K	Hold	3,900	–	–	0.09%	122
2017 Q1	$125K	Buy	3,900 +100	+3%	+$3.41K	0.09%	115
2016 Q4	$138K	Buy	+3,800	New	+$152K	0.11%	99

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Sterling Investment Advisors (Pennsylvania)'s TEVA Position: Q3 2022 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Teva Pharmaceuticals (TEVA) in Q3 2022, closing a stake of 1,000 shares — an estimated $8K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in TEVA in Q4 2016 and held it in 23 quarters. The position peaked at $138K in Q4 2016. 430 funds tracked by Wall St. Rank hold TEVA as of Q3 2022.

Sterling Investment Advisors (Pennsylvania) reported no remaining Teva Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
Sterling Investment Advisors (Pennsylvania) sold 1,000 Teva Pharmaceuticals shares in Q3 2022, an estimated $8K.
Sterling Investment Advisors (Pennsylvania) first reported a position in Teva Pharmaceuticals in Q4 2016 and held it in 23 quarters.
Sterling Investment Advisors (Pennsylvania)'s Teva Pharmaceuticals position peaked at $138K in Q4 2016.
430 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2022.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q3 2022, filed 3 Nov 2022.